These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3871182)

  • 1. HLA-B8/DR3 phenotype and the primary immune response.
    Kallenberg CG; Klaassen RJ; Beelen JM; The TH
    Clin Immunol Immunopathol; 1985 Jan; 34(1):135-40. PubMed ID: 3871182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.
    Kallenberg CG; Klaassen RJ; Westra J; Beelen JM; Ockhuizen T
    Clin Immunol Immunopathol; 1988 Jun; 47(3):333-42. PubMed ID: 3259481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.
    Modica MA; Cammarata G; Caruso C
    J Immunogenet; 1990; 17(1-2):101-7. PubMed ID: 2212697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated natural killer cytotoxicity in HLA-B8 and HLA-DR3-positive individuals.
    Jakobisiak M; Saidman S; Schlaut J; Pazderka F; Dossetor JB
    Immunol Lett; 1986 Mar; 12(2-3):61-3. PubMed ID: 3087867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
    Amer A; Singh G; Darke C; Dolby AE
    Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.
    Kallenberg CG; Van der Voort-Beelen JM; D'Amaro J; The TH
    Clin Exp Immunol; 1981 Mar; 43(3):478-85. PubMed ID: 6945162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic findings in siblings with acute sarcoid arthritis: association with the B8,DR3 phenotype.
    Kremer JM
    J Rheumatol; 1986 Jun; 13(3):593-7. PubMed ID: 3488404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased interleukin-2 receptor affinity in normal HLA A1 B8 DR3 subjects.
    Pomier G; Vindimian M; Healy JC; Le Petit JC
    J Immunogenet; 1990 Dec; 17(6):371-7. PubMed ID: 2096181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.
    Hashimoto S; McCombs CC; Michalski JP
    Clin Exp Immunol; 1989 Jun; 76(3):317-23. PubMed ID: 2787712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
    Matsui Y; Alosco SM; Awdeh Z; Duquesnoy RJ; Page PL; Hartzman RJ; Alper CA; Yunis EJ
    Immunogenetics; 1984; 20(6):623-31. PubMed ID: 6239824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2.
    Candore G; Colucci AT; Modica MA; Caruso C
    Immunopharmacol Immunotoxicol; 1991; 13(4):551-61. PubMed ID: 1774436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of platelet associated antibody levels in patients with chronic idiopathic thrombocytopenic purpura expressing the B8 and/or DR3 allotypes.
    Porges A; Bussel J; Kimberly R; Schulman I; Pollack M; Pandey J; Barandun S; Hilgartner M
    Tissue Antigens; 1985 Aug; 26(2):132-7. PubMed ID: 3877351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B8,DR3 haplotype affects lymphocyte blood levels.
    Caruso C; Bongiardina C; Candore G; Cigna D; Romano GC; Colucci AT; Di Lorenzo G; Gervasi F; Manno M; Potestio M; Tantillo G
    Immunol Invest; 1997 Apr; 26(3):333-40. PubMed ID: 9129986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytokine production by HLA-B8,DR3 positive subjects.
    Candore G; Cigna D; Gervasi F; Colucci AT; Modica MA; Caruso C
    Autoimmunity; 1994; 18(2):121-32. PubMed ID: 7742473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.
    Candore G; Cigna D; Todaro M; De Maria R; Stassi G; Giordano C; Caruso C
    Hum Immunol; 1995 Apr; 42(4):289-94. PubMed ID: 7558912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression.
    Collier PM; Wojnarowska F; Welsh K; McGuire W; Black MM
    Br J Dermatol; 1999 Nov; 141(5):867-75. PubMed ID: 10583169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte abnormality associated with HLA-B8 in healthy young adults.
    McCombs CC; Michalski JP
    J Exp Med; 1982 Sep; 156(3):936-41. PubMed ID: 6980966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
    Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
    Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.
    Godot V; Harraga S; Beurton I; Tiberghien P; Sarciron E; Gottstein B; Vuitton DA
    Clin Exp Immunol; 2000 Sep; 121(3):491-8. PubMed ID: 10971516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.